Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2025-2031

March 2025 | 117 pages | ID: GE8C860D5D48EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Prostate Cancer Diagnostics market size is predicted to grow from US$ 16320 million in 2025 to US$ 26030 million in 2031; it is expected to grow at a CAGR of 8.1% from 2025 to 2031.

The prostate is a walnut-sized gland located behind the base of a man’s penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.

Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.

Market competition is intense. Genomic Health, Abbott, OPKO, Siemens Healthcare, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. Those key players got about 4% market shares. North America region is the largest region of Prostate Cancer Diagnostics, with a revenue market share nearly 49%. Europe is the second region of Prostate Cancer Diagnostics, enjoying revenue market share nearly 28%.

LPI (LP Information)' newest research report, the “Prostate Cancer Diagnostics Industry Forecast” looks at past sales and reviews total world Prostate Cancer Diagnostics sales in 2024, providing a comprehensive analysis by region and market sector of projected Prostate Cancer Diagnostics sales for 2025 through 2031. With Prostate Cancer Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Cancer Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Prostate Cancer Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Prostate Cancer Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate Cancer Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Cancer Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Cancer Diagnostics.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Tumor Biomarker Tests
• Imaging
• Biopsy
• Other

Segmentation by Application:

• Age Below 55
• Age 55-75
• Age Above 75

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• OPKO
• Genomic Health
• Abbott
• Beckman Coulter
• Siemens Healthcare
• bioMeriux
• Roche
• MDx Health
• DiaSorin
• Myriad Genetics
• Ambry Genetics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Prostate Cancer Diagnostics Market Size (2020-2031)
  2.1.2 Prostate Cancer Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Prostate Cancer Diagnostics by Country/Region (2020, 2024 & 2031)
2.2 Prostate Cancer Diagnostics Segment by Type
  2.2.1 Tumor Biomarker Tests
  2.2.2 Imaging
  2.2.3 Biopsy
  2.2.4 Other
2.3 Prostate Cancer Diagnostics Market Size by Type
  2.3.1 Prostate Cancer Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
2.4 Prostate Cancer Diagnostics Segment by Application
  2.4.1 Age Below
  2.4.2 Age 55-75
  2.4.3 Age Above
2.5 Prostate Cancer Diagnostics Market Size by Application
  2.5.1 Prostate Cancer Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)

3 PROSTATE CANCER DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 Prostate Cancer Diagnostics Market Size Market Share by Player
  3.1.1 Global Prostate Cancer Diagnostics Revenue by Player (2020-2025)
  3.1.2 Global Prostate Cancer Diagnostics Revenue Market Share by Player (2020-2025)
3.2 Global Prostate Cancer Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PROSTATE CANCER DIAGNOSTICS BY REGION

4.1 Prostate Cancer Diagnostics Market Size by Region (2020-2025)
4.2 Global Prostate Cancer Diagnostics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Prostate Cancer Diagnostics Market Size Growth (2020-2025)
4.4 APAC Prostate Cancer Diagnostics Market Size Growth (2020-2025)
4.5 Europe Prostate Cancer Diagnostics Market Size Growth (2020-2025)
4.6 Middle East & Africa Prostate Cancer Diagnostics Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Prostate Cancer Diagnostics Market Size by Country (2020-2025)
5.2 Americas Prostate Cancer Diagnostics Market Size by Type (2020-2025)
5.3 Americas Prostate Cancer Diagnostics Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Prostate Cancer Diagnostics Market Size by Region (2020-2025)
6.2 APAC Prostate Cancer Diagnostics Market Size by Type (2020-2025)
6.3 APAC Prostate Cancer Diagnostics Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Prostate Cancer Diagnostics Market Size by Country (2020-2025)
7.2 Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025)
7.3 Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Prostate Cancer Diagnostics by Region (2020-2025)
8.2 Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2020-2025)
8.3 Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET FORECAST

10.1 Global Prostate Cancer Diagnostics Forecast by Region (2026-2031)
  10.1.1 Global Prostate Cancer Diagnostics Forecast by Region (2026-2031)
  10.1.2 Americas Prostate Cancer Diagnostics Forecast
  10.1.3 APAC Prostate Cancer Diagnostics Forecast
  10.1.4 Europe Prostate Cancer Diagnostics Forecast
  10.1.5 Middle East & Africa Prostate Cancer Diagnostics Forecast
10.2 Americas Prostate Cancer Diagnostics Forecast by Country (2026-2031)
  10.2.1 United States Market Prostate Cancer Diagnostics Forecast
  10.2.2 Canada Market Prostate Cancer Diagnostics Forecast
  10.2.3 Mexico Market Prostate Cancer Diagnostics Forecast
  10.2.4 Brazil Market Prostate Cancer Diagnostics Forecast
10.3 APAC Prostate Cancer Diagnostics Forecast by Region (2026-2031)
  10.3.1 China Prostate Cancer Diagnostics Market Forecast
  10.3.2 Japan Market Prostate Cancer Diagnostics Forecast
  10.3.3 Korea Market Prostate Cancer Diagnostics Forecast
  10.3.4 Southeast Asia Market Prostate Cancer Diagnostics Forecast
  10.3.5 India Market Prostate Cancer Diagnostics Forecast
  10.3.6 Australia Market Prostate Cancer Diagnostics Forecast
10.4 Europe Prostate Cancer Diagnostics Forecast by Country (2026-2031)
  10.4.1 Germany Market Prostate Cancer Diagnostics Forecast
  10.4.2 France Market Prostate Cancer Diagnostics Forecast
  10.4.3 UK Market Prostate Cancer Diagnostics Forecast
  10.4.4 Italy Market Prostate Cancer Diagnostics Forecast
  10.4.5 Russia Market Prostate Cancer Diagnostics Forecast
10.5 Middle East & Africa Prostate Cancer Diagnostics Forecast by Region (2026-2031)
  10.5.1 Egypt Market Prostate Cancer Diagnostics Forecast
  10.5.2 South Africa Market Prostate Cancer Diagnostics Forecast
  10.5.3 Israel Market Prostate Cancer Diagnostics Forecast
  10.5.4 Turkey Market Prostate Cancer Diagnostics Forecast
10.6 Global Prostate Cancer Diagnostics Forecast by Type (2026-2031)
10.7 Global Prostate Cancer Diagnostics Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Prostate Cancer Diagnostics Forecast

11 KEY PLAYERS ANALYSIS

11.1 OPKO
  11.1.1 OPKO Company Information
  11.1.2 OPKO Prostate Cancer Diagnostics Product Offered
  11.1.3 OPKO Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 OPKO Main Business Overview
  11.1.5 OPKO Latest Developments
11.2 Genomic Health
  11.2.1 Genomic Health Company Information
  11.2.2 Genomic Health Prostate Cancer Diagnostics Product Offered
  11.2.3 Genomic Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Genomic Health Main Business Overview
  11.2.5 Genomic Health Latest Developments
11.3 Abbott
  11.3.1 Abbott Company Information
  11.3.2 Abbott Prostate Cancer Diagnostics Product Offered
  11.3.3 Abbott Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Abbott Main Business Overview
  11.3.5 Abbott Latest Developments
11.4 Beckman Coulter
  11.4.1 Beckman Coulter Company Information
  11.4.2 Beckman Coulter Prostate Cancer Diagnostics Product Offered
  11.4.3 Beckman Coulter Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Beckman Coulter Main Business Overview
  11.4.5 Beckman Coulter Latest Developments
11.5 Siemens Healthcare
  11.5.1 Siemens Healthcare Company Information
  11.5.2 Siemens Healthcare Prostate Cancer Diagnostics Product Offered
  11.5.3 Siemens Healthcare Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Siemens Healthcare Main Business Overview
  11.5.5 Siemens Healthcare Latest Developments
11.6 bioMeriux
  11.6.1 bioMeriux Company Information
  11.6.2 bioMeriux Prostate Cancer Diagnostics Product Offered
  11.6.3 bioMeriux Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 bioMeriux Main Business Overview
  11.6.5 bioMeriux Latest Developments
11.7 Roche
  11.7.1 Roche Company Information
  11.7.2 Roche Prostate Cancer Diagnostics Product Offered
  11.7.3 Roche Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Roche Main Business Overview
  11.7.5 Roche Latest Developments
11.8 MDx Health
  11.8.1 MDx Health Company Information
  11.8.2 MDx Health Prostate Cancer Diagnostics Product Offered
  11.8.3 MDx Health Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 MDx Health Main Business Overview
  11.8.5 MDx Health Latest Developments
11.9 DiaSorin
  11.9.1 DiaSorin Company Information
  11.9.2 DiaSorin Prostate Cancer Diagnostics Product Offered
  11.9.3 DiaSorin Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 DiaSorin Main Business Overview
  11.9.5 DiaSorin Latest Developments
11.10 Myriad Genetics
  11.10.1 Myriad Genetics Company Information
  11.10.2 Myriad Genetics Prostate Cancer Diagnostics Product Offered
  11.10.3 Myriad Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Myriad Genetics Main Business Overview
  11.10.5 Myriad Genetics Latest Developments
11.11 Ambry Genetics
  11.11.1 Ambry Genetics Company Information
  11.11.2 Ambry Genetics Prostate Cancer Diagnostics Product Offered
  11.11.3 Ambry Genetics Prostate Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Ambry Genetics Main Business Overview
  11.11.5 Ambry Genetics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Prostate Cancer Diagnostics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Prostate Cancer Diagnostics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tumor Biomarker Tests
Table 4. Major Players of Imaging
Table 5. Major Players of Biopsy
Table 6. Major Players of Other
Table 7. Prostate Cancer Diagnostics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Prostate Cancer Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
Table 10. Prostate Cancer Diagnostics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Prostate Cancer Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)
Table 13. Global Prostate Cancer Diagnostics Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Prostate Cancer Diagnostics Revenue Market Share by Player (2020-2025)
Table 15. Prostate Cancer Diagnostics Key Players Head office and Products Offered
Table 16. Prostate Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Prostate Cancer Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Prostate Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Table 21. Global Prostate Cancer Diagnostics Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Prostate Cancer Diagnostics Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Prostate Cancer Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Prostate Cancer Diagnostics Market Size Market Share by Country (2020-2025)
Table 25. Americas Prostate Cancer Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
Table 27. Americas Prostate Cancer Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)
Table 29. APAC Prostate Cancer Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Prostate Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Table 31. APAC Prostate Cancer Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Prostate Cancer Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Prostate Cancer Diagnostics Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Prostate Cancer Diagnostics Market Size Market Share by Country (2020-2025)
Table 35. Europe Prostate Cancer Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Prostate Cancer Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Prostate Cancer Diagnostics Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Prostate Cancer Diagnostics Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Prostate Cancer Diagnostics Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Prostate Cancer Diagnostics
Table 41. Key Market Challenges & Risks of Prostate Cancer Diagnostics
Table 42. Key Industry Trends of Prostate Cancer Diagnostics
Table 43. Global Prostate Cancer Diagnostics Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Prostate Cancer Diagnostics Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Prostate Cancer Diagnostics Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. OPKO Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 48. OPKO Prostate Cancer Diagnostics Product Offered
Table 49. OPKO Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. OPKO Main Business
Table 51. OPKO Latest Developments
Table 52. Genomic Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 53. Genomic Health Prostate Cancer Diagnostics Product Offered
Table 54. Genomic Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Genomic Health Main Business
Table 56. Genomic Health Latest Developments
Table 57. Abbott Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 58. Abbott Prostate Cancer Diagnostics Product Offered
Table 59. Abbott Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Abbott Main Business
Table 61. Abbott Latest Developments
Table 62. Beckman Coulter Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 63. Beckman Coulter Prostate Cancer Diagnostics Product Offered
Table 64. Beckman Coulter Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Beckman Coulter Main Business
Table 66. Beckman Coulter Latest Developments
Table 67. Siemens Healthcare Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 68. Siemens Healthcare Prostate Cancer Diagnostics Product Offered
Table 69. Siemens Healthcare Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Siemens Healthcare Main Business
Table 71. Siemens Healthcare Latest Developments
Table 72. bioMeriux Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 73. bioMeriux Prostate Cancer Diagnostics Product Offered
Table 74. bioMeriux Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. bioMeriux Main Business
Table 76. bioMeriux Latest Developments
Table 77. Roche Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 78. Roche Prostate Cancer Diagnostics Product Offered
Table 79. Roche Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Roche Main Business
Table 81. Roche Latest Developments
Table 82. MDx Health Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 83. MDx Health Prostate Cancer Diagnostics Product Offered
Table 84. MDx Health Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. MDx Health Main Business
Table 86. MDx Health Latest Developments
Table 87. DiaSorin Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 88. DiaSorin Prostate Cancer Diagnostics Product Offered
Table 89. DiaSorin Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. DiaSorin Main Business
Table 91. DiaSorin Latest Developments
Table 92. Myriad Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 93. Myriad Genetics Prostate Cancer Diagnostics Product Offered
Table 94. Myriad Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Myriad Genetics Main Business
Table 96. Myriad Genetics Latest Developments
Table 97. Ambry Genetics Details, Company Type, Prostate Cancer Diagnostics Area Served and Its Competitors
Table 98. Ambry Genetics Prostate Cancer Diagnostics Product Offered
Table 99. Ambry Genetics Prostate Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Ambry Genetics Main Business
Table 101. Ambry Genetics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Prostate Cancer Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Prostate Cancer Diagnostics Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Prostate Cancer Diagnostics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Prostate Cancer Diagnostics Sales Market Share by Country/Region (2024)
Figure 8. Prostate Cancer Diagnostics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Prostate Cancer Diagnostics Market Size Market Share by Type in 2024
Figure 10. Prostate Cancer Diagnostics in Age Below 55
Figure 11. Global Prostate Cancer Diagnostics Market: Age Below 55 (2020-2025) & ($ millions)
Figure 12. Prostate Cancer Diagnostics in Age 55-75
Figure 13. Global Prostate Cancer Diagnostics Market: Age 55-75 (2020-2025) & ($ millions)
Figure 14. Prostate Cancer Diagnostics in Age Above 75
Figure 15. Global Prostate Cancer Diagnostics Market: Age Above 75 (2020-2025) & ($ millions)
Figure 16. Global Prostate Cancer Diagnostics Market Size Market Share by Application in 2024
Figure 17. Global Prostate Cancer Diagnostics Revenue Market Share by Player in 2024
Figure 18. Global Prostate Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Figure 19. Americas Prostate Cancer Diagnostics Market Size 2020-2025 ($ millions)
Figure 20. APAC Prostate Cancer Diagnostics Market Size 2020-2025 ($ millions)
Figure 21. Europe Prostate Cancer Diagnostics Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Prostate Cancer Diagnostics Market Size 2020-2025 ($ millions)
Figure 23. Americas Prostate Cancer Diagnostics Value Market Share by Country in 2024
Figure 24. United States Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Prostate Cancer Diagnostics Market Size Market Share by Region in 2024
Figure 29. APAC Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
Figure 30. APAC Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)
Figure 31. China Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 35. India Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Prostate Cancer Diagnostics Market Size Market Share by Country in 2024
Figure 38. Europe Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
Figure 39. Europe Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)
Figure 40. Germany Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 41. France Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Prostate Cancer Diagnostics Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Prostate Cancer Diagnostics Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 54. APAC Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 55. Europe Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 57. United States Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 58. Canada Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 59. Mexico Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 60. Brazil Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 61. China Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 62. Japan Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 63. Korea Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 65. India Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 66. Australia Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 67. Germany Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 68. France Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 69. UK Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 70. Italy Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 71. Russia Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 72. Egypt Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 73. South Africa Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 74. Israel Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 75. Turkey Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)
Figure 76. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Prostate Cancer Diagnostics Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Prostate Cancer Diagnostics Market Size 2026-2031 ($ millions)